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Plasma cell tumors have been induced with high frequency in BALB/c  (BALB)  1 
mice by the introduction of plastic chambers (1) or mineral oil (2) into the peritoneal 
cavity. The etiology of these tumors remains unclear. Intracisternal type-A viral par- 
ticles have been found by electron microscopy in several of the plasma cell tumors 
(3-5), and one group has recently found C-type viral particles in some of their lines 
(6). It has not been possible to prove a viral etiology for these tumors, however, since 
all attempts at induction of the tumors with cell-free extracts have been unsuccessful 
(4, 5, 7-9). Others have suggested that neoplasia of plasma cells is due to chronic anti- 
genic stimulation (10)  or to the immunosuppressive effects of mineral oil (11). 
In contrast to the extensive studies on the induction of plasma cell tumors (l-11) 
and on the proteins produced by these tumors  (12),  the search for tumor-associated 
antigens on the plasma cell tumors has received little attention. Some recent studies 
have indicated that mice can be immunized against subsequent challenge of syngeneic 
plasma cell tumors  (11,  13,  14).  The finding of transplantation antigens common to 
several plasma cell tumors (13) is consistent with a viral etiology for these tumors. 
In addition to the in vivo studies, there have been recent reports of antibodies pro- 
duced in BALB mice by immunization against plasma cell tumors (14,  15). However, 
the specificity of these reactions was not well defined. 
Cytotoxic antibodies have also been produced against BALB plasma cell tumors by 
immunization of I)BA/2 (DBA) mice (16). These antibodies appeared to demonstrate 
an  alloantigen, PC.I,  which  was present on normal plasma cells and on cells of the 
liver, kidney, brain, and lymph nodes, as well as on plasma cell tumors. 
In the present study,  cytotoxic antibodies were produced by immunization 
of BALB  mice with syngeneic plasma cell tumors.  An unexpected observation 
was that the sera of normal BALB mice also contained antibodies reactive with 
plasma cell tumors.  The specificity of the natural and immune syngeneic anti- 
bodies was  compared with the reported specificity of the  allogeneic anti-PC.1 
1  Abbreviations used in this paper: B6, C57BL/6;  BALB, BALB/c; BSS, Hanks' balanced 
salt solution;  xVEA, viral envelope antigen on MOPC-70A and MPC-113 ceils; DBA, DBA/2; 
FBS, fetal bovine serum;  GCSA, Gross ceil surface antigen; GMuLV,  Gross murine leukemia 
virus; IEM, immunoelectron microscopy; MEM, Eagle's  minimal essential medium; RI, recom- 
binant inbred strain; SBMV, southern bean mosaic virus. 
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antibody. The presence of naturally occurring antibody reacting with an antigen 
common to all plasma  cell tumors  suggested a  possible relationship to a  virus 
in these cells. Some evidence which supports this hypothesis is presented here. 
Materials  and  Methods 
Mice.--Male inbred mice were obtained from the Animal Production Branch, Division of 
Research Services, National Institutes of Health. The recombinant inbred (RI) strains, C  >( 
BD,  C  X  BE,  C  X  BG,  C  X  BH,  C  X  BI,  C  ×  B  J,  and  C  X  BK,  derived 
from the cross of BALB and C57BL/6  (B6) mice by Dr. D. W. Bailey (17) were supplied by 
Dr. Michael Potter, National Cancer Institute. 
Tumors.--The transplantable BALB  (18) and C3H/He (19) plasma cell tumors were sup- 
plied by Doctors Michael Potter, K. Robert Mclntire, and Ruth Merwin, National Cancer 
Institute. All were maintained in ascites form. Dr. Potter also supplied two oil-induced pri- 
mary plasma cell tumors of C X BD and C X  BJ. The plasma cell tissue culture lines, derived 
from C3H tumor X5563  (6), were obtained from Dr. Robert Hyman, Salk Institute, La Jolla, 
Calif. The virus-induced leukemias, RBL-3, RBL-5, MCDV-12, and LSTRA, were supplied 
by the late Dr. John Glynn and by Dr.  Michael Chirigos, NCI. The EoZG2  lymphoma in 
B6,  induced  by  passage  A  Gross  virus,  and  the  transplantable  AKR  spontaneous leu- 
kemia, K36, were obtained from Dr.  E. A. Boyse and Miss Gayla Geering, Sloan-Kettering 
Institute for Cancer Research, New York. The BALB reticulum cell sarcomas, RCS-A, MC- 
1934, and MC-2103, were produced by Dr.  Richard Asofsky, National Institute of Allergy 
and Infectious Diseases and by Dr. K. Robert McIntire, NCI. The NZB tumors were obtained 
from Dr. Robert Mellors, Hospital for Special Surgery, New York. 
Antisera.--Groups  of 20-30 mice were immunized against plasma cell tumors, according to 
the following schedules: (a)  eight weekly subcutaneous inoculations of viable MPC-110 or 
MPC-113 cells,  at doses producing tumors in 20%  or less of the recipients;  (b) four weekly 
subcutaneous doses of MPC-I10 or MPC-113 cells, treated with mitomycin C. 1 )<  107  cells 
were incubated for 3 hr at 37°C with 100/zg of mitomycin C and were then washed twice. This 
procedure was previously found to prevent tumor growth of as many as 1 X  105 MPC-110 or 
MPC-113 cells.  (c) Tumorigenic doses of plasma cell tumors were inoculated subcutaneously. 
At various times after immunization, the recipients  were bled from the retroorbital sinus under 
ether anesthesia. The serum of each group was pooled and stored at --70°C until tested. 
Normal Sera.--Normal BALB and other mice of various ages were bled. The sera from most 
of these mice were stored as individual specimens rather than as pools. 
Cell Suspensions.--(a)  Spleens, lymph nodes, and thymuses were finely minced with scalpels 
in a  few milliliters of Hanks' balanced salt solution [(BSS),  Media Production  unit,  NIH] 
supplemented with 20% heat-inactivated (at  56°C  for 30  rain)  fetal  bovine  serum  [(FBS) 
Grand Island Biological Co., Grand Island, N. Y.].  (b) Bone marrow was obtained from the 
femurs by rinsing of the marrow cavities with approximately 2 ml of BSS-FBS. (c) Tumor cells 
were obtained by harvesting ascites fluid or by mincing the solid tumor or spleen.  The tissue 
culture cells were harvested by incubation with 0.1% crystalline trypsin for 5 rain at 37°C. 
Each of the cell suspensions were washed twice in 25 ml of BSS-FBS and then adjusted to 
the  final  desired viable  concentration in  tissue  culture  medium,  Eagle's  minimal  essential 
medium (MEM) with 20% FBS. Viability of cell suspensions  was determined by exclusion of 
trypan blue dye. 
Tissue Homogenates.--Tissues  from exsanguinated mice were minced and 25%  (w/v) ho- 
mogenates were prepared with a Teflon tissue homogenizer in MEM-FBS. The protein con- 
centration of the homogenates was determined by the Lowry method (20). 
Assay for Cytotoxic Antibody.--The  method used was described in reference 21.0.1  ml of 
~lCr-labeled target cells was added to 0.1  ml of serial twofold dilutions of antiserum. After 
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complement and the incubation continued for 30 min. The supernatant from each tube was 
then counted for released radioactivity. The titer of serum was defined as the reciprocal of the 
serum dilution producing cytotoxicity twice that of the background controls. The control tubes 
contained cells alone or cells plus complement and were 5-15%  of the maximum amount of 
~tCr released by 3X  freezing and thawing of the cells. 
Quantitative  Determination  of  Antigen  by  Absorption  of Cytotoxic  Antibody.--Absorption 
studies were performed with the final dilution of serum producing 50-75% lysis. Serial twofold 
dilutions of 0.1 ml of the cells or tissue homogenates to be tested for antigenicity were incu- 
bated with 0.2 ml of serum for 30 rain at 37°C. Labeled target cells were then added and the 
mixtures tested for residual cytotoxic activity. An antigen unit was defined as the number of 
TABLE  I 
Cylotoxic Activity of Antisera Prepared by  Immunization  of BALB  Mice  with  Plasma  Cell 
Tumors 
Immunizing cell 
MPC-110 
MPC-113 
MPC-110 
MPC-113 
MPC-110 
MPC-113 
MPC-86 
RPC-20 
MOPC-28A 
RCS-A§ 
No.  and condition  of cells 
inoculated 
1  X  10  2, viable* 
1  X  10  a,  " 
1  X  10  a, treated with 
Time of bleeding 
1 wk after 8 weekly 
doses 
1 wk after 4 weekly 
Cytotoxic titer  against 
MPC-110  MPC-113 
32  64 
96  128 
32  48 
mitomycin C 
5 ×  10  4,  "  " 
1  X  10  4, viable:~ 
1  X  i0 ~,  " 
1  X  10  ~,  " 
1  X  10 ~,  " 
1  X  10  6,  " 
1  X  10  a,  " 
doses 
After 4 wks 
32 
16 
16 
8 
64 
16 
64 
64 
24 
24 
12 
64 
16 
64 
* Subthreshold dose of cells. 
:~ Tumorigenic dose of cells. 
§ Immunization with this reticulum celt sarcoma was performed when it was found that it 
contained the PC antigen. 
cells or the amount of protein in a homogenate needed to reduce the cytotoxic activity of the 
serum by 50%. 
Immunoelectron Microscopy (IEM)  (22).--Briefly,  5  ;K  106 washed test cells were  mixed 
with BALB serum. After washing, the cells were incubated with anti-mouse IgG/anti-southern 
bean mosaic virus (SBMV)  F(ab')2 hybrid antibody, and then with SBMV. The final  pellets 
of viable cells were fixed with glutaraldehyde and osmium tetroxide.  After incubation over- 
night in cold 0.5% uranyl acetate,  they were dehydrated  and  embedded  in Epon,  as usual. 
Thin sections were stained with uranyl acetate and lead citrate. 
To examine the ability of various tumors to absorb out reactivity by IEM,  the undiluted 
test serum was mixed with an equal volume of packed washed cells, incubated for 30 min on 
ice, and recovered by centrifugation in the cold. The same absorption procedure was repeated 
with fresh cells. The absorbed sera were then tested for reactivity in the usual manner. 
To control for binding of SBMV due to production of immunoglobulin on the surface of the 
myeloma cells, the reagent alone was reacted with the cells. To control for reactivity of the 
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RESULTS 
Cytotoxicity  of BALB  Immune Sera  against  Plasma Cell  Tumors.--Antisera 
produced by immunization  with syngeneic plasma cell tumors or reticulum cell 
sarcoma were tested for cytotoxic reactivity against MPC-110 and MPC-113 
cells. The results obtained with some of these sera are shown in Table I. Titers 
as high  as  128 were  obtained by multiple inoculations of  tumor cells. High- 
titered sera were also obtained from mice with progressively growing tumors. 
TABLE  II 
Cytotoxic Activity  of Sera of Normal BALB/c  Mice  against Plasma  Cell Tumors 
Description of serum donors 
Type  Age  No. of mice  %  of mice  Mean titer:~ 
tested  positive* 
months  % 
Conventional  1  20  70  3.6 
"  2  40  85  5.7 
"  3  40  93  6.8 
"  4  30  90  7.4 
"  5  10  90  6.4 
"  6  20  80  5.8 
"  7-8  10  80  5.2 
"  9  12  20  70  4.6 
Germfree  1  10  20  2.0 
"  2  10  50  3.3 
"  34  15  60  4.1 
Germfree, transferred to con- 
ventional conditions at 1 
month of age 
3  10  90  6.9 
* Serial twofold dilutions of sera, beginning at  1:2,  were tested.  Sera were considered 
negative if the 1:2 dilution did not show reactivity. 
:~ Geometric mean of the titers of the positive sera. 
Similar titers were seen against both of the target cells, with the tendency for 
the results with MPC-113 to be somewhat higher. MPC-113 was therefore used 
as the target cell for most of the subsequent studies. None of the sara had detect- 
able cytotoxic activity against normal BALB spleen cells. 
Cytotoxicity of Normal BALB Sara against Plasma Cell Tumors.--During  the 
studies with the immune BALB sara, it was noted that sara from control mice, 
which had not been inoculated with plasma cell tumors, had low levels of cyto- 
toxic reactivity. This unexpected and interesting finding was investigated fur- 
ther.  Sara from individual normal BALB mice of various ages were tested for 
cytotoxic reactivity against MPC-113 cells (Table II). Most of the 190 normal 
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ity was seen in sera of 3-4-month old mice, with frequency of positive reactions 
and mean titers significantly higher (P < 0.05,  Student's t test) than those of the 
1-month old and 9-12-month old mice. Some of the older mice were retired ex- 
breeders, but this background did not appear to influence reactivity. 
To determine the serial changes in cytotoxic reactivity, a group of 10 1-month 
old mice were bled every 4 wk for 6 months. Four of these mice had no detect- 
able cytotoxic reactivity when they were 1 month old; all developed reactivity 
by 4  months  of age.  Three of the  mice,  which  were previously reactive,  lost 
detectable serum cytotoxicity by the last bleeding. 
The finding of cytotoxic reactivity in the sera of most normal BALB, which 
tended to increase with age, indicated that the reactivity may have been related 
to sensitization by environmental  agents.  Therefore, similar studies were per- 
formed with germfree mice (Table II). The frequency and amount of reactivity 
at  all  ages tested was significantly lower  than  those  of animals  raised under 
conventional conditions. Germfree mice which were transferred to conventional 
conditions, at 1 month of age, developed reactivity which was indistinguishable 
from conventional mice. 
Characteristics of the Cytotoxic Reactivity in Normal Sera.--The cytotoxic re- 
activity of the normal BALB sera was presumed to be due to natural antibodies. 
It was important,  however, to obtain supportive evidence for this. A  pool of 
normal BALB serum, from 3-4-month old mice with a titer of eight, was used 
in these studies. The cytotoxic reactions were shown to be dependent on com- 
plement. Incubation of the sera with target cells, without the addition of rabbit 
complement, resulted in no lysis. A variety of procedures known to inactivate 
or inhibit C' activity was performed with normal rabbit serum before, or during, 
the  incubation  with  target cells  (23).  In each case,  inhibition  of complement 
activity was associated with loss of cytotoxic reactivity. 
To determine whether the material responsible for the cytotoxic activity be- 
haved like  an  immunoglobulin,  assays were performed with  serum fractions. 
The cytotoxic activity was precipitable by 33 %  saturated  ammonium sulfate. 
Gel filtration  of immune BALB  serum on  Sephadex  G-200  (Pharmacia Fine 
Chemicals, Inc., Piscataway, N. J.) yielded activity mainly in the 7S  region. 
In the normal BALB serum, activity was also found in the void volume, in those 
fractions containing  IgM. The antibody nature  of the cytotoxic activity was 
further confirmed by its specificity, as indicated by the absorption experiments 
and bv the reaction with the anti-mouse IgG reagent in the IEM studies. 
Cylotoxicity of Sera of Mice from Other Strains.--The occurrence of natural 
antibodies reactive with the plasma cell tumors was reminiscent of the natural 
antibodies  to  the  Gross leukemia antigen  (24).  With  the  Gross system,  anti- 
bodies were only found in some strains of mice. It was of interest to determine 
whether the antibody reactive with plasma cell tumors also had a characteristic 
strain  distribution.  Sera  of  normal  mice  from  seven  different  inbred  mouse 
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All strains were found to be reactive. Initially, sera from young A/He mice were 
tested and found to be negative. However, sera from older mice gave positive 
results. With the small number of sera tested from each strain, it is difficult to 
state whether there are characteristic differences in reactivity among the strains. 
Specificity of Antibodies Reactive with Plasma Cell Tumors.--A pool of normal 
BALB serum, which was reactive with MPC-113,  was tested against a  series of 
plasma  cell  tumors,  and  against  other  tumor  cells  and  normal  BALB  cells 
(Table IV). The serum was cytotoxic against all of the BALB  plasma cell tu- 
mors, including TEPC-18  and BFPC-3511  which were solid tumors in the first 
transplant  generation.  There  was  no  relationship between  reactivity and  the 
type of immunoglobulin produced by the tumor cells. The serum also reacted 
TABLE  III 
Cytotoxic Activity of Sera of Normal  Mice of  Various Strains  against  Plasma  Cell  Tumors 
Strain  Age  No. of mice  % of mice  Mean  titer 
tested  positive 
months  % 
B6  2  11  82  3.6 
"  4  6  83  7.6 
"  10  5  80  4.5 
DBA  3  5  80  6.5 
C3H/HeN  3  5  80  4.7 
AKR  3  5  60  2.8 
A/He  1  4  0  0 
"  4  5  100  4.9 
SJL/J  3  5  80  6.7 
NZB  3  5  80  7.6 
BALB  2  40  85  5.7 
"  4  30  90  7.4 
with three reticulum cell sarcomas which did not produce paraproteins. Positive 
results were  also obtained with  the  C3H  plasma cell tumor,  X5563,  and with 
the  cell line,  C1,  derived from  it.  It was  of interest,  that  the  cell line, XC1, 
which  did not  produce  immunoglobulin  and  lacked detectable virus particles 
(6),  was negative. The serum also did not react against leukemias induced by 
Moloney or Rauscher virus or against normal BALB cells. 
Absorption tests were performed to further demonstrate the specificity of the 
cytotoxic reaction, and to determine whether an antigen common to all plasma 
cell tumors was  responsible for the observed reactions.  All of the plasma cell 
tumors,  except XC1,  were  able to  remove activity (Table V),  although  there 
were varying amounts  of  antigen  on the  different cells. The  BALB  reticulum 
cell sarcomas were positive, but SJL/J  and NZB  reticulum cell sarcomas had 
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able antigen. Negative results were also obtained with other leukemias, induced 
by viruses or by carcinogens. 
The PC.1  antigen has been found on all plasma cell tumors tested and was 
not detected on other BALB leukemias (16). It was therefore of interest to com- 
pare  the  specificity of  the  normal BALB  serum  antibody with  the  reported 
specificity of the anti-PC. 1 antiserum. The tissue and strain distribution  of anti- 
TABLE IV 
Cytotoxic Activity of Normal BALB Serum* against  Variety  of Target  Cells 
Target cell  Cytotoxic titer 
BALB plasma cell tumors 
MPC-110  6 
MPC-113  8 
MPC-80  4 
MPC-86  3 
MPC-105  2 
RPC-20  8 
MOPC-28A  8 
MOPC-70A  6 
MOPC-104E  6 
TEPC-18  2 
BFPC-3511  4 
BALB reticulum cell sarcomas 
RCS-A  8 
MC-1934  4 
M  C  -2103  2 
BALB leukemias, induced by leukemia virus 
LSTRA  0 
MCDV-12  0 
BALB normal cells 
Spleen cells  0 
Lymph node cells  0 
C3H plasma cell tumors 
X5563  4 
C1  4 
XC1  0 
* Pool of serum from 20 BALB mice, 3 months of age. 
gen reactive with the normal BALB serum was found to be identical with that 
of PC.1 (Table VI). In BALB mice the antigen was detected on spleen cells and 
lymph node cells and in homogenates of liver, kidney, and brain. The other 
positive strains were C3H/He, A/He, NZB, and SJ-L/J. No antigen was found 
in spleen cells from DBA, B6, or 129 mice. 
Most  of  these  absorptions were  performed  with  tissues  from  2-month old 
mice. A  possible explanation for the decreased serum reactivity in older mice 
was  that  the  antigen content of  the  tissues increased with  age  and removed TABLE  V 
Antigenic  Activity  of Plasma  Cell  Tumors  and  of Other Tumor  Cells 
Cells used for absorption 
BALB plasma cell tumors 
MPC-110 
MPC-113 
MPC-80 
MPC-86 
MPC-105 
RPC-20 
MOPC-28A 
MOPC-70A 
C3H plasma cell tumors 
X5563 
C1 
XCI 
Plasma cell tumors, primary, 
from RI strains 
CXBD 
CXBJ 
BALB reticulum cell sar- 
comas 
RCS-A 
MC-1934 
MC-2103 
SJL/J reticulum cell sarcomas 
(6 primary tumors tested) 
NZB reticulum cell sarcomas 
(2 transplanted tumors 
tested) 
Mouse leukemias 
BALB LSTRA 
BALB/MCDV-12 
Origin of cells 
Chamber induced 
Oil induced 
Spontaneous 
Tissue culture line derived 
from X5563 
Oil induced 
B6 RBL-5 
B6 Ec~G2 
B6 EL-4 
DBA L1210 
AKR K36 
Spontaneous in germfree 
mice 
Oil induced 
Spontaneous 
Spontaneous 
Moloney virus induced 
Rauscher virus induced 
Gross virus induced 
Benzo[a]pyrene induced 
3-Methylcholanthrene in- 
duced 
Spontaneous (Gross virus 
positive) 
Antigenic activity* 
Normal BALB/c  Immune 
serum~t  BALB/c  serum§ 
5X 
lX 
lX 
lX 
IX 
lX 
5X 
2X 
2X 
lX 
>lX 
IX 
IX 
lX 
lX 
1X 
>lX 
>IX 
cells~antigen  unit 
>1  X  10 s 
>1  X  10  8 
>1  X  l0  s 
>1  X  l0  s 
>1  X  10  s 
>1  X  l0  s 
1  X  l0 s 
10  a  1  X  106 
106  2  X  106 
107 
107  5 X  106 
107 
107 
105  5 X  l0  s 
106  1  X  l0  G 
106  1 X  106 
106 
108 
106 
107 
10  6  1  X  10  6 
107 
107 
l0  s 
10 s 
>1  X  10 s 
>1  X  10 8 
>1  X  10 s 
>1  X  10 s 
>1  X  10 s 
1 X  108 
* Method: 0.2 ml of serum incubated with 0.1 ml of serial twofold dilutions of cells for 30 
min at 37°C.  Serum tested for residual cytotoxicity against MPC-113 cells. One unit of an- 
tigen =  number of cells  needed to reduce cytotoxic activity by 50%. 
Normal BALB  serum pool, from 3-month old mice, tested at  1:6 dilution. 
§ Serum produced by eight weekly injections of 1 X  10  a viable MPC-113 cells,  tested at 
1 : 80 dilution. 
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some  of  the  antibody.  Absorption  was  therefore  performed  with  spleen  cells 
from  10-month  old BALB  mice.  No  increase in  antigen was  found;  in fact,  a 
decreased  quantity  was  present  (Table  VI).  Spleen  cells  from  10-month 
B6  mice  had no detectable activity.  I'herefore it seemed unlikely that  absorp- 
TABLE  VI 
Tissue and Strain  Distribution  qf Antigen Reactive with BALB  Serum  and of PC.I  Antigen 
Cells used for absorption 
BALB normal tissues 
Spleen cells 
Liver homogenate 
Kidney bomogenate 
Brain homogenate 
Lymph node cells 
Cells from thynms or bone 
marrow; erythrocytes 
Spleen cells from 1-month old 
germfree mice 
Spleen cells from 10-month old 
mice 
Liver homogenate from 14-day 
fetuses 
Kidney homogenate from 14- 
day fetuses 
DBA normal tissues 
Spleen and lymph node cells 
Homogenates of liver, kidney, 
and brain 
C3H/He spleen cells 
A/He  .... 
NZB  "  " 
SJL/J  .... 
B6  .... 
129  .... 
Antigenic activity* 
Normal BALB serum  Immune BALB serum 
Cells or mg  p;'otein/antigen  unit 
1 X  10  v cells 
1 mg 
0.5 mg 
0.25 mg 
1 X  lO  s cells 
>1  X  lO  s cells 
1 X  l0  s cells 
5  X  107 cells 
0.5 mg 
0.25 mg 
> 1 X  l0  s cells 
>5 mg 
4  X  10  z cells 
2  X  10  z cells 
1 X  10  7 cells 
2  X  10  z cells 
> 1 X  10 s cells:~ 
> 1 X  10  s cells 
2 X  10 z cells 
1 mg 
>1  X  10 scells 
>1  X  10  scells 
2  X  107 cells 
2  X  107 cells 
4  X  107 ceils 
2  X  10  z cells 
>1  X  10  s cells 
>1  X  l0  s cells 
Presence 
of PC.1 
antigen, 
from (16) 
+ 
+ 
+ 
2- 
4- 
NT§ 
NT 
NT 
NT 
+ 
+ 
+ 
+ 
* Absorption with 0.1  ml of serial twofold  dilutions of cells or  tissue homogenate.  One 
unit of antigen =  number of cells or amount of protein (rag)  in homogenate needed to re- 
duce cytotoxic activity by 50~Jc. 
~C Cells from 2-month old and 10-month old mice were tested. 
§ NT, not tested. 
tion of antibody by tissue antigens could  account for the decreased  serum  acti- 
vity. 
Since the sera of germfree BALB  mice were  less reactive  against the plasma 
cell tumors, it was possible that the tissues lacked the antigen. However, antigen 
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in lower quantity compared with conventional 1-month old mice. Tissues from 
14-day BALB fetuses were also antigen positive. 
As a further test of whether the natural BALB antibody and the anti-PC.1 
antiserum both reacted with PC.1  antigen,  absorption studies were done with 
spleen cells from RI strains  (17).  These strains were derived from a  cross be- 
tween BALB  (PC.1  +)  and B6  (PC.l-)  strains and had been previously typed 
for  distribution  of  PC.1  antigen (Itakura,  unpublished  observations).  The 
absorption studies gave the same pattern as that obtained for PC.1 (Table VII), 
Dr.  Michael Potter has been able to induce plasma cell tumors in C  X  BD, 
C  X  BG, and C  X  BJ mice (unpublished observations). Two primary tumors 
were tested for absorption with the normal BALB serum (Table V) ; both had 
activity. 
When  absorption  studies  were performed with  one  of the  BALB  antisera 
TABLE  VII 
Presence of Antigen Reactive with Normal BALB Serum and of PC.1 Antigen in RI Strains 
Derived from BALB and B6 
Strain  tI-Z type (17)  Antigenic activity  Presence of PC.1 
antigen* 
spleen cells~antigen unit 
C  X  BD  d  2.5  X  10  z  + 
C  X  BK  b  5.0  X  10  ~  + 
C  X  BE  b  >1  X  l0 s  - 
C  X  BG  b  >1  X  10  8  -- 
C  X  BH  d  >1  X  lO  s  -- 
C  X  BI  b  >  1  X  10  s  -- 
C X BJ  b  >1 X  10 s  - 
* Data  of Dr. Itakura  (unpublished). 
produced  by  immunization  with  plasma  cell  tumors  (anti-MPC-113  viable 
cells),  a  similar pattern  of results  was  obtained  (Table V).  Activity  against 
MPC-113  cells was removed by all of the plasma cell  tumors tested  and by 
normal BALB and A/He spleen cells. The AKR leukemia, K36, had some anti- 
genic activity. Other tumor cells  and DBA  and B6 spleen  cells gave negative 
results. 
Absorption studies were also performed with pooled serum from 3-month old 
B6 mice to determine whether it had the same specificity as the  antibody in 
the BALB  sera.  The same pattern of absorption was found. Activity against 
MPC-113  cells  was  removed  by  MPC-113  and  MOPC-70A  and  by  nor- 
mal spleen cells.  The B6 leukemia Eo  ~ G2 and B6 spleen cells had no detectable 
activity. 
Intracisternal  A  particles  have  been  observed  by  electron  microscopy in 
plasma cell tumors (3-5) and in thoracic duct lymphocytes (25) of BALB mice. 
It was of interest to determine whether there was a direct relationship between 104  ANTIBODIES  TO  SYNGENEIC  MURINE  PLASMA  CELL  TUMORS 
these particles and the antigen under study. 1 mg of isolated A particles (9) was 
obtained from I)r.  E.  Kuff,  National  Cancer Institute.  This preparation was 
unable to remove cytotoxic activity from the normal BALB serum pool. 
Immunoelectron Microscope Studies.--In previous studies by IEM the typing 
serum for PC.1  was  shown  to  contain  antibodies  to virus-related  antigens  in 
addition to antibody to PC.1 (22). The antiserum reacted with GCSA and PC.l, 
and with a new viral envelope antigen, xVEA, on the virus in MPOC-70A cells. 
Since the antiserum was produced by immunization with MOPC-70A,  it was 
possible  that  the  detected  viral  envelope  antigen  was  particularly  associated 
Test serum 
Test  cell  Serum  Interpretation 
(B6xDBA/2)F F anti-MOPC 70A myeloma cells  from untreated  BALB mice 
(standard  PC typing serum} 
MOPC-70A  BALB  =~  ~ 
myeloma cells  ......... 
(pC+,GCSA  +)  GCSA,PC xVEA  PC  xVEA 
MPC-113  BALB  #~  .7,~--~ 
myeloma cells  .......  (PC  +, GCSA')  PC  X  VEA  PC  x VEA 
Serum from untreated 
BALI] mice reacts 
both with the 
viral envelope antigen, 
X  VEA,  and with the cell 
surface  antigen,  PC. 
E,o2o  ....  ©  © 
leukemia cel Is  ....  (~--~-- 
(pc  °, GCSA  +}  GCSA  (all negative)  ] 
Serum from untreated 
I 
BALB mice has no 
reactivity with the Gross 
(~  (~  t  viral ....  lope antigen, 
K36 wild-type Gross  GVEA, nor with GCSA. 
leukemia cells  ......  /~  " "  "  f'~ 
(pc  +, GCSA  +  )  GCSA,PC  PC 
FIG. 1. Comparison  between reactions of the standard PC-typing hyperimmune serum and 
the serum from untreated BALE mice with the surface of murine myeloma and leukemia cells 
and viruses. 
with that tumor cell rather than widely distributed on other plasma cell tumors 
or in the environment. The pooled serum of untreated BALB mice, which had 
been shown to have cytotoxic antibody to PC antigen, was examined by IEM 
and compared with the standard PC  antiserum  (B6  X  DBA)F1 anti-MOPC- 
70A. A  summary of the results  are given in Fig.  1. The BALB  serum reacted 
with both the viral envelope and the cell surface of MOPC-70A (GCSA  + PC  +) 
(Fig. 2) as well as MPC-113 (GCSA-PC +)  (Fig. 3) but not with those of EcPG2 
leukemia (GCSA+PC  -) which was induced by passage A  Gross leukemia virus 
(GMuLV).  In  addition,  cells  of the transplanted  AKR spontaneous leukemia 
K36 (GCSA+PC +) were labeled with the BALB serum on very small restricted 
areas of the cell surface, but not on the envelope of wild-type GMuLV. Absorp- RONALD  B.  HERBER~AN  AND  TADAO  AOKI  105 
tion of the BALB serum with K36 cells removed reactivity with the MOPC-70A 
cell surface, but not with the viral envelope. The main difference of these results 
from those previously obtained with the standard PC.1  antiserum is that the 
BALB serum did not contain antibody to GCSA.  The  absence of antibody to 
GMuLV-related antigens in the BALB serum was confirmed by absorption tests 
with Ec~ G2 cells. No removal of activity with the surface of MOPC-70A virus 
and cells was seen. 
DISCUSSION 
The present study confirmed the previous observation that mufine plasma 
cell  tumors contain  common cell  surface  antigens  which  can be detected  by 
antibodies (15,  16). The finding of common antigens on tumor cells,  rather than 
individually specific antigens, could be due to association with a virus or to the 
presence of tissue-specific antigens. The present data indicate that the antigen 
is not really tumor specific, since it was found in some normal tissues as well as 
plasma tumor cells.  This does not, however, rule out an association of the anti- 
gen with a virus, since leukemia virus-related antigens have been found in nor- 
mal tissues (26,  27). 
The distribution of the antigen reactive with the immune and natural anti- 
bodies was identical with that reported for the PC.1  antigen  (16)  and presum- 
ably the two antigens  are the same. The antisera to PC.1  were produced by 
immunization  of an antigen negative strain,  DBA  with  a  BALB  plasma cell 
tumor. No tests with normal DBA or BALB sera were reported (16). Yamada 
et  al.  (14)  obtained negative results with normal BALB  sera.  Our finding of 
cytotoxic reactivity of normal BALB and other sera was unexpected. It is likely 
that positive results were obtained because of the use of undiluted rabbit serum 
as the source of complement, which has been shown to be more effective than 
guinea pig serum for lysis of murine nucleated cells (28,  29). The strict depend- 
ence on complement,  the fractionation of the cytotoxic factor with  immuno- 
globulins,  the reactivity with anti-mouse IgG reagent in IEM, and the speci- 
ficity of the reactions strongly indicate that natural antibodies were responsible 
for the activity. 
The finding of widespread natural antibodies to PC.1 needs to be accounted 
for. To our knowledge,  this has not been observed with the major  histocom- 
patibility antigens or other alloantigens. The presence of antibody in the  sera 
of both  PC.1 +  and  PC.I-  strains was particularly suprising.  The  absorption 
studies indicated  that the antibodies in normal BALB  and B6 serum had the 
same specificity. One possible explanation is that the antibodies were evoked 
by an environmental agent or by an occult antigen in the PC.1 negative strains. 
Sensitization by exposure to an environmental antigen, even in the PC.I  + mice, 
could explain most of the findings. Germfree BALB mice had lower reactivity 
than conventional mice. This reactivity rapidly increased after the transfer of 
germfree mice to conventional conditions. The presence or absence of antigen FIG.  2.  BALB  myeloma MOPC-70A  cells  were  reacted  with  the  serum  from  untreated 
BALB  mice and  labeled  with  SBMV.  (a)  The entire  surface of extracellular  C-type viruses 
was labeled  with SBMV.  >(  100,000.  (b)  Very small restricted  areas of the cell surface were 
labeled with SBMV.  )<  80,000. 
106 FIO.  3. BALB  myeloma MPC-113  cells were reacted with the pooled serum of untreated 
BALB mice and labeled with SBMV.  X  70,000. Amount of surface antigen is larger than that 
on MOPC-70A cells (cf. Fig. 2 b). 
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in tissues of the animals did not appear to have an important role in the time 
of appearance or the titer of antibody. It is possible that the exogenous route 
or the amount of exposure may be important factors in  the  development of 
antibodies against the PC.1  antigen.  Inoculation of BALB mice with  plasma 
cell tumors resulted in  higher titers than those found in any normal sera. The 
decline in natural antibody titers with age could not be accounted for by ab- 
sorption by an increased level of tissue antigen. The spleens of 10-month old 
BALB mice did not contain as much antigen as  those of younger mice,  and 
antigen did not appear in the spleens of 10-month old B6 mice. 
It  seems  likely that  there  are  one or more viruses closely associated with 
plasma cell tumors. Several electron microscope studies have shown virus par- 
ticles in plasma cell tumors (3-6). Gross leukemia virus-related antigens have 
been found in some plasma cell tumors (22, 30, 31). However, other plasma cell 
tumors lack the Gross specific cell surface antigen but have the GCSA(b) anti- 
gen, which appears to be common to tumors infected by all murine leukemia 
viruses (31). The MOPC-70A tumor contains GCSA and reacts with sera from 
aged NZB mice, indicating the probable presence of the Gross viral envelope 
antigen (22).  The IEM studies indicate that the virus in this tumor also con- 
tains a viral envelope antigen, xVEA, distinct from that of Gross leukemia virus 
(22). Several possible explanations could be offered for these findings. Plasma 
cell tumors may contain different variants of Gross leukemia virus, with expres- 
sion of some or all of its associated antigens. An alternative explanation is that 
the presence of Gross virus-related antigens in some plasma cell tumors is due 
to chance contamination by the virus, which appears to occur with other types 
of tumors (26). A third, but somewhat unlikely, possibility is that the virus of 
MOPC-70A is a hybrid between GMuLV and the virus associated with xVEA. 
A reasonable hypothesis to account for the natural antibodies  to  PC.1  and 
the virologic data is that there is a virus, distinct from the previously described 
leukemia viruses, which induces the formation of PC.1  antigen. The finding of 
PC.1 antigen in some normal tissues could be due to the presence of the latent 
virus.  Aaronson  et  al.  (32)  have  recently provided  evidence to  support  the 
hypothesis of latent virus in some normal BALB cells. 
If PC.  1 antigen is indeed induced by  a  virus,  the  characteristic  strain 
distribution of the antigen and the results of the immunogenetic studies  06) 
must be explained. As Boyse and Old (33) have discussed in regard to TL anti- 
gen, and as predicted by the Huebner and Todaro oncogene theory (34), inte- 
gration of viral genetic information into the cell  genome of some strains is  a 
possibility. Alternatively, host genetic factors could determine the stable per- 
sistence of virus or expression of latent virus in normal cells. It is possible that 
this virus  is  intimately associated with  the induction of plasma  cell tumors. 
Oils  and plastic  chambers might  activate latent virus. The RI strains  are of 
interest in this regard.  Potter has successfully induced plasma cell tumors in 
the PC.l- strains, C X  BG, and C )< BJ. However. a plasma cell tumor arising RONALD B.  HERBERMAN  AND  TADAO  AOKI  109 
in  C  X  BJ was found to contain the PC.1  antigen.  This indicates that even 
PC.I- strains have the information needed to code for antigen expression. This 
observation is similar to the  appearance of TL antigen in some leukemias of 
TL- strains (33). 
The relationship of the PC. I antigen to the intracisternal A particles remains 
unclear.  Antigen was not found on isolated A  particles, but this was not sur- 
prising since PC.1 is a cell surface antigen rather than a viral envelope antigen. 
It will be of interest to determine whether isolated A particles can induce PC.1 
antigen in negative strains. 
There is precedence for the occurrence of natural antibodies to murine tumor 
viruses. Aoki et al. (24) have found antibodies to Gross leukemia virus-induced 
cell surface antigen  in the  sera of many normal mice. There  are some major 
differences,  however, between  the  Gross system and  the  plasma cell  system. 
Antibody to Gross antigen was only found in strains with  a  low incidence of 
spontaneous leukemia, and the antibody was found mainly in old mice. IEM 
showed reactivity with Gross antigen in sectors on the cell surface but not with 
virus particles  (35).  In contrast,  antibody to PC.1  antigen was present in the 
sera of all strains examined, including those with a high incidence of inducible 
plasma cell tumors. Peak antibody activity was found  at 3-4 months of age 
and then declined in later life. IEM study of normal BALB serum showed reac- 
tivity with viral envelope as well as cell surface antigen. The biological role of 
the natural  antibody  to PC.1  and  the  reasons for its differences from Gross 
antibody remain to be determined. 
SUMMARY 
Cytotoxic antibody to a plasma cell tumor antigen was produced in syngeneic 
BALB  mice by immunization with viable or inactivated plasma cell tumors. 
Antibody with the same specificity was found in the sera of normal BALB and 
other strains of mice. This natural antibody reacted with an antigen with char- 
acteristics indistinguishable  from the  previously described  alloantigen,  PC.l, 
and with viral envelope antigen,  xVEA. The incidence of cytotoxic reactivity 
and the antibody titers reached a peak in normal BALB mice at 3-4 months of 
age,  and were lower in 9-12-month old mice. The sera of germfree mice had 
lower reactivity; but when the mice were transferred to conventional conditions, 
their sera soon became as active as those of conventional mice. 
A virus common to all plasma cell tumors, which is present in latent form in 
some normal tissues of BALB and other PC.1 positive strains, is suggested as 
the cause for the PC.1  antigen and for the appearance of natural antibody to 
it. The considerable evidence for the close association of a virus with plasma 
cell tumors is presented. 
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